Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through Akt-eNOS-NO-HIF pathway

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Guo, Jia Y ^a   Yang, Tong ^a   Sun, Xiang G ^a   Zhou, Ni Y ^a   Li, Fu S ^a   Long, Dan ^a   Lin, Tao ^a   Li, Ping Y ^a   Feng, Li ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; MALONALDEHYDE; NITRIC OXIDE; PROTEIN KINASE B; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; HIF1A PROTEIN, MOUSE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; ISCHEMIC POSTCONDITIONING; ISCHEMIC REPERFUSION INJURY; LIVER FUNCTION; LIVER INJURY; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BLOOD; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; METHODOLOGY; PATHOLOGY; RAT;

MUS;

ALANINE TRANSAMINASE; ANIMALS; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR ADHESION MOLECULE-1; ISCHEMIC POSTCONDITIONING; LIVER; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXIDASE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054985592     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-79     Document Type: Article

References (71)

1. Recent insights on the mechanisms of liver preconditioning. Carini R, Albano E, Gastroenterology 2003 125 1480 1491 10.1016/j.gastro.2003.05.005 14598265 (Pubitemid 37409769)
2. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. Oshima Y, Fujio Y, Nakanishi T, Itoh N, Yamamoto Y, Negoro S, Tanaka K, Kishimoto T, Kawase I, Azuma J, Cardiovasc Res 2005 65 428 435 10.1016/j.cardiores.2004.10.021 15639482 (Pubitemid 40082485)
3. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J, Am J Physiol Heart Circ Physiol 2003 285 579 588
4. Endothelial NOS activity and myocardial oxygen metabolism define the salvageable ischemic time window for ischemic postconditioning. Cai M, Li Y, Xu Y, Swartz HM, Chen CL, Chen YR, He G, Am J Physiol Heart Circ Physio 2011 300 1069 1077 10.1152/ajpheart.00694.2010
5. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Lønborg J, Kelbaek H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Treiman M, Jensen JS, Engstrøm T, Circ Cardiovasc Interv 2010 3 34 41 10.1161/ CIRCINTERVENTIONS.109.905521 20118154
6. Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats. Penna C, Tullio F, Moro F, Folino A, Merlino A, Pagliaro P, Basic Res Cardiol 2010 105 181 192 10.1007/s00395-009-0075-6 20012872
7. Role of phosphoinositide 3-kinase in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice. Rehni AK, Singh N, Pharmacol Rep 2007 59 192 198 17556797 (Pubitemid 46952409)
8. Attenuation of reperfusion injury by renal ischemic postconditioning: the role of NO. Liu X, Chen H, Zhan B, Xing B, Zhou J, Zhu H, Chen Z, Biochem Biophys Res Commun 2007 359 628 634 10.1016/j.bbrc.2007.05.129 17548062 (Pubitemid 46898997)
9. Ischemic postconditioning inhibits apoptosis after renal ischemia/reperfusion injury in rat. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z, Transpl Int 2008 21 364 371 10.1111/j.1432-2277.2007.00606.x 18069925 (Pubitemid 351348006)
10. Effect of ischemic post-conditioning on spinal cord ischemic-reperfusion injury in rabbits. Huang H, Zhang L, Wang Y, Yao J, Weng H, Wu H, Chen Z, Liu J, Can J Anaesth 2007 54 42 48 10.1007/BF03021898 17197467 (Pubitemid 46178785)
11. The ischemic preconditioning and postconditioning effect on the intestinal mucosa of rats undergoing mesenteric ischemia/reperfusion process. Santos CHM, Gomes OM, Pontes JCDV, Miiji LNO, Bispo MA, Acta Cir Bras 2008 23 22 28 18278389 (Pubitemid 351378636)
12. Postconditioning effect in the hepatic ischemia and reperfusion in rats. Santos CH, Pontes JC, Miiji LN, Nakamura DI, Galhardo CA, Aguena SM, Acta Cir Bra 2010 25 163 168
13. Preconditioning and postconditioning reduce hepatic ischemia-reperfusion injury in rats. Zhang WX, Yin W, Zhang L, Wang LH, Bao L, Tuo HF, Zhou LF, Wang CC, Hepatobiliary Pancreat Dis Int 2009 8 586 590 20007074
14. Postconditioning ameliorates lipid peroxidation in liver ischemia-reperfusion injury in rats. Teixeira AR, Molan NT, Kubrusly MS, Bellodi-Privato M, Coelho AM, Leite KR, Machado MA, Bacchella T, Machado MC, Acta Cir Bras 2009 24 52 56 19169543
15. AT1 receptor blockade in experimental myocardial ischemia/reperfusion. Jalowy A, Schulz R, Heusch G, J Am Soc Nephrol 1999 10 129 136 9892153
16. Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase. Kubota I, Han X, Opel DJ, Zhao YY, Baliga R, Huang P, Fishman MC, Shannon RP, Michel T, Kelly RA, J Mol Cell Cardiol 2000 32 1239 1248 10.1006/jmcc.2000.1158 10860766
17. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. Yang XM, Proctor JB, Cui L, J Am Coll Cardiol 2004 44 1103 1110 10.1016/j.jacc.2004.05.060 15337225 (Pubitemid 39165147)
18. Attenuation of reperfusion injury by renal ischemic postconditioning: the role of NO. Liu X, Chen H, Zhan B, Xing B, Zhou J, Zhu H, Chen Z, Biochem Biophys Res Commun 2007 359 628 634 10.1016/j.bbrc.2007.05.129 17548062 (Pubitemid 46898997)
19. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. Kasuno K, Takabuchi S, Fukuda K, Kizaka-Kondoh S, Yodoi J, Adachi T, Semenza GL, Hirota K, J Biol Chem 2004 279 2550 2558 14600153 (Pubitemid 38114240)
20. Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3K pathway. Sandau KB, Faus HG, Brune B, Biochem Biophys Res Commun 2000 278 263 267 10.1006/bbrc.2000.3789 11071882
21. Activation of the oxygen-sensing signal cascade prevents mitochondrial injury after mouse liver ischemia-reperfusion. Zhong Z, Ramshesh VK, Rehman H, Currin RT, Sridharan V, Theruvath TP, Kim I, Wright GL, Lemasters JJ, Am J Physiol Gastrointest Liver Physiol 2008 295 823 832 10.1152/ajpgi.90287.2008 18772364
22. Adenosine-dependent activation of hypoxia-inducible factor-1 induces late preconditioning in liver cells. Alchera E, Tacchini L, Imarisio C, Dal Ponte C, De Ponti C, Gammella E, Cairo G, Albano E, Carini R, Hepatology 2008 48 230 239 10.1002/hep.22249 18506850 (Pubitemid 351975548)
23. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-akt pathway. Tsang A, Hausenloy DJ, Mocanu MM, Circ Res 2004 95 230 232 10.1161/01.RES.0000138303. 76488.fe 15242972 (Pubitemid 39056282)
24. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Yang XM, Philipp S, Downey JM, Bas Res Cardiol 2005 100 57 63 10.1007/s00395-004-0498-4 (Pubitemid 40069107)
25. Grape seed proanthocyanidins protect cardiomyocytes from ischemia and reperfusion injury via Akt-NOS signaling. Shao ZH, Wojcik KR, Dossumbekova A, Hsu C, Mehendale SR, Li CQ, Qin Y, Sharp WW, Chang WT, Hamann KJ, Yuan CS, Hoek TL, J Cell Biochem 2009 107 697 705 10.1002/jcb.22170 19388003
26. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: The roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA, Ma XL, Circulation 2002 105 1497 1502 10.1161/01.CIR.0000012529. 00367.0F 11914261 (Pubitemid 34263284)
27. Insulin inhibits tumor necrosis factor-alpha induction in myocardial ischemia/reperfusion: Role of Akt and endothelial nitric oxide synthase phosphorylation. Li J, Zhang H, Wu F, Nan Y, Ma H, Guo W, Wang H, Ren J, Das UN, Gao F, Crit Care Med 2008 36 1551 1558 10.1097/CCM.0b013e3181782335 18434880 (Pubitemid 351620675)
28. A novel inhibitor of Rho-associated protein kinase, Y-27632, ameliorates hepatic ischemia and reperfusion injury in rats. Takeda K, Jin MB, Fujita M, Fukai M, Sakurai T, Nakayama M, Taniguchi M, Suzuki T, Shimamura T, Furukawa H, Todo S, Surgery 2003 133 197 206 10.1067/msy.2003.59 12605181 (Pubitemid 36407984)
29. The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion. Peralta C, Perales JC, Bartrons R, Mitchell C, Gilgenkrantz H, Xaus C, Am J Pathol 2002 160 2111 2122 10.1016/S0002-9440(10) 61160-1 12057915 (Pubitemid 34663403)
30. A simple method for clinical assay of superoxide dismutase. Sun Y, Oberley LW, Li Y, Clin Chem 1988 34 497 500 3349599
31. Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha. Lu DY, Liou HC, Tang CH, Fu WM, Biochem Pharmacol 2006 72 992 1000 10.1016/j.bcp.2006.06.038 16919605 (Pubitemid 44374459)
32. Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Wood J, Garthwaite J, Neuropharmacology 1994 33 1235 1244 10.1016/0028-3908(94)90022-1 7870284 (Pubitemid 24353714)
33. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. Lang JD Jr, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, Liu Y, Jhala N, Crowe DR, Smith AB, Cross RC, Frenette L, Kelley EE, Wilhite DW, Hall CR, Page GP, Fallon MB, Bynon JS, Eckhoff DE, Patel RP, J Clin Invest 2007 117 2583 2591 10.1172/JCI31892 17717604 (Pubitemid 47494359)
34. The hepatic haemodynamic effects of nitric oxide. Mathie RT, In the haemodynamic effects of nitric oxide London: Imperial College Press, Mathie RT, Griffith TM, 1 1999 22 51
35. Sexual dimorphism in reduced-size liver ischemia and reperfusion injury in mice: Role of endothelial cell nitric oxide synthase. Harada H, Pavlick KP, Hines IN, Lefer DJ, Hoffman JM, Bharwani S, Wolf RE, Grisham MB, Proc Natl Acad Sci USA 2003 100 739 744 10.1073/pnas.0235680100 12522262 (Pubitemid 36126122)
36. Enhanced post-ischemic liver injury in iNOS-deficient mice: a cautionary note. Hines IN, Harada H, Bharwani S, Pavlick KP, Hoffman JM, Grisham MB, Biochem Biophys Res Commun 2001 284 972 976 10.1006/bbrc.2001.5069 11409889 (Pubitemid 32924743)
37. Ahluwalia A Role for endothelial nitric oxide synthase in nitrite-induced protection against renal ischemia-reperfusion injury in mice. Milsom AB, Patel NS, Mazzon E, Tripatara P, Storey A, Mota-Filipe H, Sepodes B, Webb AJ, Cuzzocrea S, Hobbs AJ, Thiemermann C, Nitric Oxide 2010 22 141 148 10.1016/j.niox.2009.10.010 19892029
38. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Jones SP, Greer JJ, Kakkar AK, Ware PD, Turnage RH, Hicks M, van Haperen R, de Crom R, Kawashima S, Yokoyama M, Lefer DJ, Am J Physiol Heart Circ Physiol 2004 286 276 H282 12969888
39. Differential response to myocardial reperfusion injury in eNOS-deficient mice. Sharp BR, Jones SP, Rimmer DM, Lefer DJ, Am J Physiol Heart Circ Physiol 2002 282 2422 H2426 12003854
40. The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury. Frantz S, Adamek A, Fraccarollo D, Tillmanns J, Widder JD, Dienesch C, Schäfer A, Podolskaya A, Held M, Ruetten H, Ertl G, Bauersachs J, Basic Res Cardiol 2009 104 773 779 10.1007/s00395-009-0041-3 19548059
41. Leucocyte adherence to venular endothelium during ischemia-reperfusion. Granger DN, Benoit JN, Suzuki M, Grisham MB, Am J Physiol 1989 257 683 688 2596604
42. Expression of antioxidant enzymes in rat kidney during ischemia-reperfusion injury. Singh I, Gulati S, Orak JK, Singh AK, Mol Cell Biochem 1993 125 97 104 10.1007/BF00936438 8283974 (Pubitemid 23312726)
43. The cardiovascular effects and implications of peroxynitrite. Ronson RS, Nakamura M, Vinten-Johansen J, Cardiovasc Res 1999 44 47 59 10.1016/S0008- 6363(99)00184-4 10615389 (Pubitemid 29431683)
44. Nitric oxide inactivates NADPH oxidase in pig neutrophils by inhibiting its assembling process. Fujii H, Ichimori K, Hoshiai K, Nakazawa H, J Biol Chem 1997 272 32773 32778 10.1074/jbc.272.52.32773 9407051 (Pubitemid 28023609)
45. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Kojda G, Harrison D, Cardiovascular Research 1999 43 562 571 10.1016/S0008-6363(99) 00169-8 10690328 (Pubitemid 29369255)
46. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Murphy ME, Sies H, Proc Natl Acad Sci USA 1991 88 10860 10864 10.1073/pnas.88.23.10860 1961756 (Pubitemid 21915938)
47. HIF-1 activation attenuates post-ischemic myocardial injury: a role for heme oxygenase-1 in modulating microvascular chemokine generation. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA, Kukreja RC, Am J Physiol Heart Circ Physiol 2005 289 542 548 10.1152/ajpheart.00089.2005 15805230 (Pubitemid 41129367)
48. Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling. Xi L, Taher M, Yin C, Salloum F, Kukreja RC, Am J Physiol Heart Circ Physiol 2004 287 2369 2375 10.1152/ajpheart.00422.2004 15284066 (Pubitemid 39557104)
49. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, Semenza GL, Circulation 2003 108 79 85 10.1161/01.CIR.0000078635.89229.8A 12796124 (Pubitemid 36859024)
50. Ischemic preconditioning mediated cardioprotection is disrupted in heterozygous Flt-1 (VEGFR-1) knockout mice. Addya S, Shiroto K, Turoczi T, Zhan L, Kaga S, Fukuda S, Surrey S, Duan LJ, Fong GH, Yamamoto F, Maulik N, J Mol Cell Cardiol 2005 38 345 351 10.1016/j.yjmcc.2004.11.033 15698841 (Pubitemid 40215204)
51. Early stress protein gene expression in a human model of ischemic preconditioning. Patel A, van de Poll MC, Greve JW, Buurman WA, Fearon KC, McNally SJ, Harrison EM, Ross JA, Garden OJ, Dejong CH, Wigmore SJ, Transplantation 2004 78 1479 1487 10.1097/01.TP.0000144182.27897.1E 15599312 (Pubitemid 39552934)
52. Regulation of hypoxia-inducible factor-1 by nitric oxide through mitochondriadependent and -independent pathways. Mateo J, Garcia-Lecea M, Cadenas S, Hernandez C, Moncada S, Biochem J 2003 376 537 544 10.1042/BJ20031155 14531732 (Pubitemid 38010539)
53. Nitric oxide and superoxide: Interference with hypoxic signaling. Brüne B, Zhou J, Cardiovasc Res 2007 75 275 282 10.1016/j.cardiores.2007. 03.005 17412315 (Pubitemid 46961919)
54. Regulation of HIF-1alpha stability through S-nitrosylation. Li F, Sonveaux P, Rabbani ZN, Liu S, Yan B, Huang Q, Vujaskovic Z, Dewhirst MW, Li CY, Mol Cell 2007 26 63 74 10.1016/j.molcel.2007.02.024 17434127 (Pubitemid 46550936)
55. HIF-1 alpha protein as a target for S-nitrosation. Sumbayev VV, Budde A, Zhou J, Brune B, FEBS Lett 2003 535 106 112 10.1016/S0014-5793(02)03887-5 12560087 (Pubitemid 36126364)
56. The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Brüne B, Zhou J, Curr Med Chem 2003 10 845 855 10.2174/0929867033457746 12678687 (Pubitemid 36443239)
57. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima Y, Hashimoto K, D'Acquisto F, Makuuchi M, Esumi H, J Biol Chem 2001 276 2292 2298 11056166 (Pubitemid 32109715)
58. Hypoxic inducible factor 1alpha, extracellular signalregulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Thomas DD, Espey MG, Ridnour LA, Hofseth LJ, Mancardi D, Harris CC, Wink DA, Proc Natl Acad Sci USA 2004 101 8894 8899 10.1073/pnas.0400453101 15178764 (Pubitemid 38781582)
59. NO and TNF-alpha released from activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1 cells. Zhou J, Fandrey J, Schumann J, Tiegs G, Brüne B, Am J Physiol Cell Physiol 2003 284 439 446 12388069
60. The role of nitric oxide in tumour progression. Fukumura D, Kashiwagi S, Jain RK, Nat Rev Cancer 2006 6 521 534 10.1038/nrc1910 16794635 (Pubitemid 43980541)
61. Hypoxia inducible factor-1 improves the actions of nitric oxide and natriuretic peptides after simulated ischemia-reperfusion. Luciano JA, Tan T, Zhang Q, Huang E, Scholz P, Weiss HR, Cell Physiol Biochem 2008 21 421 428 10.1159/000129634 18453749 (Pubitemid 351620295)
62. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Hausenloy DJ, Yellon DM, Cardiovasc Res 2004 61 448 460 10.1016/j.cardiores. 2003.09.024 14962476 (Pubitemid 38210151)
63. Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery. Ndiaye M, Chataigneau M, Lobysheva I, Chataigneau T, Schini-Kerth VB, FASEB J 2005 19 455 457 15623569 (Pubitemid 40316548)
64. The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. Gao X, Zhang H, Takahashi T, Hsieh J, Liao J, Steinberg GK, Zhao H, J Neurochem 2008 105 943 55 10.1111/j.1471-4159.2008.05218.x 18182053 (Pubitemid 351562746)
65. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Zhu M, Feng J, Lucchinetti E, Fischer G, Xu L, Pedrazzini T, Schaub MC, Zaugg M, Cardiovasc Res 2006 72 152 162 (Pubitemid 44310638)
66. Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in-vivo lymphocyte migration in the rat. Issekutz TB, J Immunol 1990 144 2140 2146 2107253 (Pubitemid 20106551)
67. Hemorrhage activates myocardial NFkB and increases tumor necrosis factor in the heart. Meldrum DR, Shenkar R, Sheridan BC, Cain BS, Abraham E, Harken AH, J Mol Cell Cardiol 1997 29 2849 2854 10.1006/jmcc.1997.0506 9344778 (Pubitemid 27466506)
68. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, Hashida M, J Pharmacol Exp Ther 2001 298 894 899 11504782 (Pubitemid 32761901)
69. NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression. Lindemann S, Sharafi M, Spiecker M, Buerke M, Fisch A, Grosser T, Gierer C, Ibe W, Meyer J, Darius H, Thromb Res 2000 97 113 123 10.1016/S0049-3848(99)00162-0 10680642 (Pubitemid 30055276)
70. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. Liu P, Xu B, Hock CE, Nagele R, Sun FF, Wong PY, Am J Physiol 1998 275 2191 198 9843819
71. Protective role of nitric oxide in ischemia and reperfusion injury of the liver. Shimamura T, Zhu Y, Zhang S, Jin MB, Ishizaki N, Urakami A, Totsuka E, Kishida A, Lee R, Subbotin V, Furukawa H, Starzl TE, Todo S, J Am Coll Surg 1999 188 43 52 10.1016/S1072-7515(98)00259-2 9915241 (Pubitemid 29031969)